(Q58271154)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

The metabolic syndrome and cardiovascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

cardiovascular disease

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Enzo Bonora

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

64-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

Associazione di iperlipemia, diabete mellito e obesita' di medio grado

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Hyperinsulinemia--how innocent a bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Prognosis after stroke in diabetic patients. A controlled prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Relation of body weight to development of coronary heart disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Obesity and lipoprotein cholesterol in the Framingham offspring study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Metabolic implications of body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The double jeopardy of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Sodium-lithium countertransport: physiology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Prognostic value of coronary vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Etiology and prognostic significance of albuminuria in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Predictors of insulin sensitivity in Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Insulin resistance and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Cross-sectional but not longitudinal associations between non-esterified fatty acid levels and glucose intolerance and other features of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Adiponectin and Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Is fasting leptin associated with insulin resistance among nondiabetic individuals? The Miami Community Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Covered stent septal ablation for hypertrophic obstruction cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Role of oxidative modifications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Vascular function, insulin resistance and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Serum uric acid and related factors in 500 hospitalized subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

C-reactive protein and incident cardiovascular events among men with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Circulating adhesion molecules in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Leptin induces hypertrophy via p38 mitogen-activated protein kinase in rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Nonhypoglycemic effects of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

Toll-like Receptor 4 Polymorphisms and Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500401234

10.1080/07853890500401234

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16448990%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference